Schoenherr has advised Ceres Pharma on the acquisition of the Hungarian pharmaceutical companies VitaPlus and Innopharm, including their Innopharm Austrian subsidiary.
Ceres Pharma is a Belgium-based pharmaceutical company founded in 2017 by Mario Debel and Alychlo and acquired in 2021 by Naxicap Partners. It is active in the development and distribution of drugs, medical devices, biocides, cosmetics, food supplements, and pharmaceutical preparations in Benelux, Italy, and Central and Eastern Europe.
VitaPlus is a Hungarian pharmaceutical company active in the development and distribution of food supplements and medical devices in Hungary and beyond.
The Schoenherr team included Hungary-based Partner Kinga Hetenyi, Attorneys at Law Adrian Menczelesz, Aron Hegyi, and Mark Kovacs, and Associates Akos Kovacs, Zsofia Rideg, and Noemi Csiki and Austria-based Counsel Teresa Waidmann, Attorneys at Law Alfred Amann and Alexander Pabst, and Associate Verena Krikler.
